BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38498346)

  • 1. Resolvin D2 limits atherosclerosis progression via myeloid cell-GPR18.
    Lipscomb M; Walis S; Marinello M; Mena HA; MacNamara KC; Spite M; Fredman G
    FASEB J; 2024 Mar; 38(6):e23555. PubMed ID: 38498346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolvin D2-GPR18 Signaling on Myeloid Cells Limits Plaque Necrosis.
    Lipscomb M; Walis S; Marinello M; Mena HA; Spite M; Fredman G
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of resolvin D2 receptor mediating resolution of infections and organ protection.
    Chiang N; Dalli J; Colas RA; Serhan CN
    J Exp Med; 2015 Jul; 212(8):1203-17. PubMed ID: 26195725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Resolvin D2-GPR18 Axis Enhances Bone Marrow Function and Limits Hepatic Fibrosis in Aging.
    Fitzgerald H; Bonin JL; Sadhu S; Lipscomb M; Biswas N; Decker C; Nabage M; Bossardi R; Marinello M; Mena AH; Gilliard K; Spite M; Adam A; MacNamara KC; Fredman G
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The resolvin D2 - GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice.
    Bardin M; Pawelzik SC; Lagrange J; Mahdi A; Arnardottir H; Regnault V; Fève B; Lacolley P; Michel JB; Mercier N; Bäck M
    Biochem Pharmacol; 2022 Jul; 201():115075. PubMed ID: 35525326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target.
    Zhao M; Zheng Z; Yin Z; Zhang J; Qin J; Wan J; Wang M
    Pharmacol Res; 2023 Sep; 195():106832. PubMed ID: 37364787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvin D2-G-Protein Coupled Receptor 18 Enhances Bone Marrow Function and Limits Steatosis and Hepatic Collagen Accumulation in Aging.
    Fitzgerald H; Bonin JL; Khan S; Eid M; Sadhu S; Rahtes A; Lipscomb M; Biswas N; Decker C; Nabage M; Ramos RB; Duarte GA; Marinello M; Chen A; Aydin HB; Mena HA; Gilliard K; Spite M; DiPersio CM; Adam AP; MacNamara KC; Fredman G
    Am J Pathol; 2023 Dec; 193(12):1953-1968. PubMed ID: 37717941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formation.
    Bellotti P; Ladd Z; Leroy V; Su G; Sharma S; Hartman JB; Krebs J; Viscardi C; Maile R; Moldawer LL; Efron P; Sharma AK; Upchurch GR
    bioRxiv; 2024 Feb; ():. PubMed ID: 38464077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.
    Zhang MJ; Sansbury BE; Hellmann J; Baker JF; Guo L; Parmer CM; Prenner JC; Conklin DJ; Bhatnagar A; Creager MA; Spite M
    Circulation; 2016 Aug; 134(9):666-680. PubMed ID: 27507404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR18 Agonist Resolvin D2 Reduces Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage by Multiple Protective Mechanisms.
    Zhang T; Zuo G; Zhang H
    Cell Mol Neurobiol; 2022 Oct; 42(7):2379-2392. PubMed ID: 34089427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Resolvin D2 Receptor Axis in Infectious Inflammation.
    Chiang N; de la Rosa X; Libreros S; Serhan CN
    J Immunol; 2017 Jan; 198(2):842-851. PubMed ID: 27994074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolvin D2 Relieving Radicular Pain is Associated with Regulation of Inflammatory Mediators, Akt/GSK-3β Signal Pathway and GPR18.
    Zhang LY; Liu ZH; Zhu Q; Wen S; Yang CX; Fu ZJ; Sun T
    Neurochem Res; 2018 Dec; 43(12):2384-2392. PubMed ID: 30443715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering the Power of GPR18 Signalling: How RvD2 and Other Ligands Could Have the Potential to Modulate and Resolve Inflammation in Various Health Disorders.
    Honkisz-Orzechowska E; Łażewska D; Baran G; Kieć-Kononowicz K
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors.
    Rodrigues-Diez R; Ballesteros-Martinez C; Moreno-Carriles RM; Nistal F; Díaz Del Campo LS; Cachofeiro V; Dalli J; García-Redondo AB; Redondo JM; Salaices M; Briones AM
    Biomed Pharmacother; 2024 May; 174():116564. PubMed ID: 38608525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
    Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
    J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.
    Pope NH; Salmon M; Davis JP; Chatterjee A; Su G; Conte MS; Ailawadi G; Upchurch GR
    FASEB J; 2016 Dec; 30(12):4192-4201. PubMed ID: 27619672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of GPR18 by Resolvin D2 Relieves Pain and Improves Bladder Function in Cyclophosphamide-Induced Cystitis Through Inhibiting TRPV1.
    Lu Q; Yang Y; Zhang H; Chen C; Zhao J; Yang Z; Fan Y; Li L; Feng H; Zhu J; Yi S
    Drug Des Devel Ther; 2021; 15():4687-4699. PubMed ID: 34815664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats.
    Zuo G; Zhang D; Mu R; Shen H; Li X; Wang Z; Li H; Chen G
    Mol Brain; 2018 Feb; 11(1):9. PubMed ID: 29439730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis.
    Siddiqui YD; Omori K; Ito T; Yamashiro K; Nakamura S; Okamoto K; Ono M; Yamamoto T; Van Dyke TE; Takashiba S
    Front Immunol; 2019; 10():307. PubMed ID: 30863409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
    Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
    Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.